Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Sana Biotechnology, Inc. (SANA) had Return on Assets of -14.11% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-58.83M |
|
-- |
|
-- |
|
$61.20M |
|
$-61.20M |
|
$2.37M |
|
$-58.83M |
|
$-58.83M |
|
$-58.83M |
|
$-58.83M |
|
$-58.83M |
|
$-58.83M |
|
$-61.20M |
|
$-58.15M |
|
253.23M |
|
253.23M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$148.68M |
|
$26.91M |
|
$268.21M |
|
$416.89M |
|
$78.73M |
|
-- |
|
$177.28M |
|
$256.01M |
|
$160.88M |
|
$-38.94M |
|
$160.88M |
|
266.73M |
|
| Cash Flow Statement Financials | |
$-143.83M |
|
$-40.24M |
|
$128.73M |
|
$131.40M |
|
$76.06M |
|
$-55.33M |
|
$25.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-143.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-36.56% |
|
151.07% |
|
|
Return on Assets |
-14.11% |
-36.56% |
|
$0.60 |
|
$-0.57 |
|
$-0.57 |
|